{"id":2638,"date":"2019-10-23T15:33:27","date_gmt":"2019-10-23T19:33:27","guid":{"rendered":"http:\/\/localhost:10028\/whitepapers\/opioid-settlement-and-teva-pharmaceutical-industries\/"},"modified":"2022-06-27T02:34:10","modified_gmt":"2022-06-27T06:34:10","slug":"opioid-abwicklung-und-teva-pharmaindustrie","status":"publish","type":"whitepapers","link":"https:\/\/napolilaw.lemonadestand.org\/de\/weise-papiere\/opioid-abwicklung-und-teva-pharmaindustrie\/","title":{"rendered":"Opioid-Siedlung und Teva Pharmaceutical Industries"},"content":{"rendered":"<p><strong>Welche Medikamente stellt Teva her?\u00a0<\/strong><\/p>\n<p>It specializes primarily in generic drugs. Some of the opioid drugs include oxycodone and fentanyl, which is a synthetic opiate. Another\u00a0is oxymorphone.<\/p>\n<p>Terms of a\u00a0deal involving McKesson Corp., Cardinal Health Inc., AmerisourceBergen Corp. and Teva Pharmaceutical Industries Ltd. were expected to be announced later in the day. Cuyahoga County lawyer Hunter Shkolnik says the settlement amounts to $260 million.<\/p>\n<p>The Ohio case had been slated to be the first federal trial related to an\u00a0opioid crisis that has claimed an estimated 400,000 American lives\u00a0over two decades.<\/p>","protected":false},"excerpt":{"rendered":"<p>Welche Medikamente stellt Teva her? Es ist vor allem auf Generika spezialisiert. Zu den Opioiden geh\u00f6ren Oxycodon und Fentanyl, ein synthetisches Opiat. Ein weiteres ist Oxymorphon. Gesch\u00e4ftsbedingungen \u2026<\/p>","protected":false},"featured_media":0,"menu_order":245,"template":"","whitepaper_category":[57,75,98,253,254],"whitepaper-source":[271],"class_list":["post-2638","whitepapers","type-whitepapers","status-publish","hentry","whitepaper_category-hunter-shkolnik","whitepaper_category-opioids-litigation","whitepaper_category-ohio-opioid-lawyers","whitepaper_category-opioid-crisis","whitepaper_category-opioid-epidemic","whitepaper-source-usa-today-network"],"acf":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepapers\/2638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepapers"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/types\/whitepapers"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepapers\/2638\/revisions"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/media?parent=2638"}],"wp:term":[{"taxonomy":"whitepaper_category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepaper_category?post=2638"},{"taxonomy":"whitepaper-source","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/de\/wp-json\/wp\/v2\/whitepaper-source?post=2638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}